1. Home
  2. UFPT vs SUPN Comparison

UFPT vs SUPN Comparison

Compare UFPT & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UFPT
  • SUPN
  • Stock Information
  • Founded
  • UFPT 1963
  • SUPN 2005
  • Country
  • UFPT United States
  • SUPN United States
  • Employees
  • UFPT N/A
  • SUPN N/A
  • Industry
  • UFPT Medical/Dental Instruments
  • SUPN Biotechnology: Pharmaceutical Preparations
  • Sector
  • UFPT Health Care
  • SUPN Health Care
  • Exchange
  • UFPT Nasdaq
  • SUPN Nasdaq
  • Market Cap
  • UFPT 1.8B
  • SUPN 1.9B
  • IPO Year
  • UFPT 1993
  • SUPN 2012
  • Fundamental
  • Price
  • UFPT $249.61
  • SUPN $31.70
  • Analyst Decision
  • UFPT Buy
  • SUPN Hold
  • Analyst Count
  • UFPT 2
  • SUPN 2
  • Target Price
  • UFPT $392.00
  • SUPN $36.00
  • AVG Volume (30 Days)
  • UFPT 201.9K
  • SUPN 685.5K
  • Earning Date
  • UFPT 07-29-2025
  • SUPN 08-05-2025
  • Dividend Yield
  • UFPT N/A
  • SUPN N/A
  • EPS Growth
  • UFPT 31.41
  • SUPN N/A
  • EPS
  • UFPT 8.15
  • SUPN 1.11
  • Revenue
  • UFPT $547,560,000.00
  • SUPN $667,997,000.00
  • Revenue This Year
  • UFPT $22.16
  • SUPN N/A
  • Revenue Next Year
  • UFPT $5.60
  • SUPN $12.02
  • P/E Ratio
  • UFPT $30.64
  • SUPN $28.89
  • Revenue Growth
  • UFPT 34.43
  • SUPN 11.82
  • 52 Week Low
  • UFPT $178.26
  • SUPN $25.55
  • 52 Week High
  • UFPT $366.41
  • SUPN $40.28
  • Technical
  • Relative Strength Index (RSI)
  • UFPT 59.06
  • SUPN 48.95
  • Support Level
  • UFPT $239.43
  • SUPN $30.93
  • Resistance Level
  • UFPT $256.98
  • SUPN $32.78
  • Average True Range (ATR)
  • UFPT 8.01
  • SUPN 1.00
  • MACD
  • UFPT 0.66
  • SUPN -0.03
  • Stochastic Oscillator
  • UFPT 71.61
  • SUPN 46.56

About UFPT UFP Technologies Inc.

UFP Technologies Inc is a designer and custom manufacturer of components, subassemblies, products, and packaging utilizing specialized foams, films, and plastics for the medical market. The company manufactures its products by converting raw materials using laminating, molding, radio frequency and impulse welding, and fabricating manufacturing techniques. It is an important link in the medical device supply chain and a valued outsource partner to many of the top medical device manufacturers in the world. The company's single-use and single-patient devices and components are used in a wide range of medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods, and orthopedic implant packaging.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.

Share on Social Networks: